Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rubric Capital Management LP and David Rosen reported beneficial ownership of Nurix Therapeutics, Inc. common stock. They collectively hold 7,227,778 shares of common stock, representing 6.96% of the class. The ownership is held through Rubric Capital–managed funds, including Rubric Capital Master Fund LP, which has rights to receive dividends and sale proceeds on more than 5% of the shares.
The percentage ownership is based on 103,781,683 shares outstanding of Nurix common stock as of June 30, 2026, as referenced from the company’s quarterly report. All reported voting and dispositive powers are shared, with no sole voting or dispositive power reported by the filing parties.
Key Figures
Shares beneficially owned:7,227,778 sharesPercent of class:6.96%Shares outstanding:103,781,683 shares+2 more
5 metrics
Shares beneficially owned7,227,778 sharesNurix Therapeutics common stock reported by Rubric Capital and David Rosen
Percent of class6.96%Portion of Nurix common stock class beneficially owned by the reporting persons
Shares outstanding103,781,683 sharesNurix common stock outstanding as of June 30, 2026, per quarterly report
Shared voting power7,227,778 sharesShares over which the reporting persons have shared power to vote
Shared dispositive power7,227,778 sharesShares over which the reporting persons have shared power to dispose
"the beneficial owner of the Shares reported herein"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
shared voting powerfinancial
"Shared Voting Power 7,227,778.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive powerfinancial
"Shared Dispositive Power 7,227,778.00"
investment adviserfinancial
"the investment adviser to certain investment funds"
An investment adviser is a person or firm that professionally manages money and gives recommendations about buying, selling, or holding investments. Like a financial coach or guide, they have a legal duty to act in a client's best financial interest, so their advice, fees and potential conflicts can directly affect returns and risk — making their role important for investors who want informed, accountable help with portfolios.
percent of classfinancial
"Percent of class: 6.96 %"
Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in Nurix Therapeutics (NRIX) does Rubric Capital report on this Schedule 13G?
Rubric Capital and David Rosen report beneficial ownership of 7,227,778 shares of Nurix Therapeutics common stock, representing 6.96% of the outstanding class, based on 103,781,683 shares outstanding as of June 30, 2026.
How many Nurix Therapeutics (NRIX) shares are outstanding for the 6.96% calculation?
The 6.96% ownership figure is based on 103,781,683 shares of Nurix Therapeutics common stock outstanding as of June 30, 2026, as reported in Nurix’s Quarterly Report for the period ended May 31, 2026.
Does Rubric Capital have sole or shared voting power over Nurix Therapeutics (NRIX) shares?
Rubric Capital and David Rosen report 0 shares with sole voting power and 7,227,778 shares with shared voting power. They likewise report shared dispositive power over the same 7,227,778 shares, with no sole dispositive power.
Who ultimately benefits from Rubric Capital’s Nurix Therapeutics (NRIX) holdings?
The Nurix shares are held for Rubric Funds advised by Rubric Capital. Rubric Capital Master Fund LP, one such fund, has the right to receive dividends or proceeds from the sale of more than 5% of Nurix’s common stock.
Who are the reporting persons for this Nurix Therapeutics (NRIX) ownership disclosure?
The reporting persons are Rubric Capital Management LP, investment adviser to the Rubric Funds holding Nurix shares, and David Rosen, Managing Member of Rubric Capital Management GP LLC, the general partner of Rubric Capital.
Where are Rubric Capital and David Rosen based in this Nurix Therapeutics (NRIX) filing?
The principal business office for both reporting persons is 155 East 44th St, Suite 1630, New York, NY 10017. Rubric Capital is a Delaware limited partnership, and David Rosen is a citizen of the United States.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Nurix Therapeutics, Inc.
(Name of Issuer)
Common Stock, $0.001 par value per share
(Title of Class of Securities)
67080M103
(CUSIP Number)
06/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
67080M103
1
Names of Reporting Persons
Rubric Capital Management LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
7,227,778.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
7,227,778.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
7,227,778.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
6.96 %
12
Type of Reporting Person (See Instructions)
IA, PN
SCHEDULE 13G
CUSIP Number(s):
67080M103
1
Names of Reporting Persons
David Rosen
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
7,227,778.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
7,227,778.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
7,227,778.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
6.96 %
12
Type of Reporting Person (See Instructions)
HC, IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Nurix Therapeutics, Inc.
(b)
Address of issuer's principal executive offices:
1600 Sierra Point Parkway, Brisbane, CA 94005
Item 2.
(a)
Name of person filing:
This statement is filed by:
(i) Rubric Capital Management LP ("Rubric Capital"), the investment adviser to certain investment funds and/or accounts (collectively, the "Rubric Funds") that hold the shares of Common Stock, $0.001 par value per share (the "Common Stock") of Nurix Therapeutics, Inc., a Delaware corporation (the "Issuer") reported herein; and
(ii) David Rosen ("Mr. Rosen"), Managing Member of Rubric Capital Management GP LLC, the general partner of Rubric Capital.
The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons."
The filing of this statement should not be construed as an admission that any of the forgoing persons or any Reporting Person is, for the purposes of Section 13 of the Act, the beneficial owner of the Shares reported herein.
(b)
Address or principal business office or, if none, residence:
The address of the principal business office of each of the Reporting Persons is 155 East 44th St, Suite 1630, New York, NY 10017.
(c)
Citizenship:
Rubric Capital is a Delaware limited partnership. Mr. Rosen is a citizen of the United States of America.
(d)
Title of class of securities:
Common Stock, $0.001 par value per share
(e)
CUSIP Number(s):
67080M103
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
The information required by Items 4(a) - (c) is set forth in Rows 9 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
The percentage set forth in Row (11) of the cover page for each of the Reporting Persons and in Item 4(b) is based on 103,781,683 shares Common Stock outstanding as of June 30, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended May 31, 2026 filed with the Securities and Exchange Commission on July 9, 2026.
(b)
Percent of class:
6.96 %
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
The information required by Item 4(c)(i) is set forth in Row 5 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(ii) Shared power to vote or to direct the vote:
The information required by Item 4(c)(ii) is set forth in Row 6 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(iii) Sole power to dispose or to direct the disposition of:
The information required by Item 4(c)(iii) is set forth in Row 7 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(iv) Shared power to dispose or to direct the disposition of:
The information required by Item 4(c)(iv) is set forth in Row 8 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
See Item 2(a). Rubric Capital Master Fund LP, a Rubric Fund, has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, more than 5% of the Common Stock.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
